Santen Pharmaceutical Co Ltd
TSE:4536

Watchlist Manager
Santen Pharmaceutical Co Ltd Logo
Santen Pharmaceutical Co Ltd
TSE:4536
Watchlist
Price: 1 670.5 JPY 0.39% Market Closed
Market Cap: 606.7B JPY
Have any thoughts about
Santen Pharmaceutical Co Ltd?
Write Note

Relative Value

The Relative Value of one Santen Pharmaceutical Co Ltd stock under the Base Case scenario is 1 536.6 JPY. Compared to the current market price of 1 670.5 JPY, Santen Pharmaceutical Co Ltd is Overvalued by 8%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
1 536.6 JPY
Overvaluation 8%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
46
vs Industry
49
Median 3Y
1.7
Median 5Y
2.1
Industry
2.5
Forward
2
vs History
47
vs Industry
19
Median 3Y
18.4
Median 5Y
23.5
Industry
21.9
Forward
16.9
vs History
87
vs Industry
37
Median 3Y
9.5
Median 5Y
12.2
Industry
16.5
vs History
90
vs Industry
28
Median 3Y
17.9
Median 5Y
25.2
Industry
23.6
vs History
30
vs Industry
37
Median 3Y
1.6
Median 5Y
1.8
Industry
2.1
vs History
46
vs Industry
52
Median 3Y
1.6
Median 5Y
1.9
Industry
2.6
Forward
1.8
vs History
46
vs Industry
56
Median 3Y
2.7
Median 5Y
3.2
Industry
5.2
vs History
60
vs Industry
33
Median 3Y
9.2
Median 5Y
11.8
Industry
13.3
Forward
8.3
vs History
49
vs Industry
28
Median 3Y
11.3
Median 5Y
14.8
Industry
16.6
Forward
10.5
vs History
87
vs Industry
40
Median 3Y
8.9
Median 5Y
11.1
Industry
15.6
vs History
90
vs Industry
30
Median 3Y
25.2
Median 5Y
27.2
Industry
19.1
vs History
28
vs Industry
37
Median 3Y
1.5
Median 5Y
1.7
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Santen Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Santen Pharmaceutical Co Ltd
TSE:4536
594.1B JPY 2 22.1 9.3 13.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
JP
Santen Pharmaceutical Co Ltd
TSE:4536
Average P/E: 31.1
22.1
61%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top